AKAN
Akanda Corp
NASDAQ · Pharmaceuticals
$0.96
+0.06 (+6.34%)
Open$0.93
Previous Close$0.90
Day High$1.02
Day Low$0.91
52W High$32.17
52W Low$14.34
Volume—
Avg Volume580.5K
Market Cap1.93M
P/E Ratio16.70
EPS$1.53
SectorPharmaceuticals
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 777.7K | 707.3K | 858.5K |
| Net Income | 128.9K | 94.3K | 103.5K |
| Profit Margin | 16.6% | 13.3% | 12.1% |
| EBITDA | 197.3K | 212.4K | 232.8K |
| Free Cash Flow | 80.3K | 76.9K | 86.9K |
| Rev Growth | -2.7% | +7.8% | +11.5% |
| Debt/Equity | 0.46 | 0.49 | 0.52 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |